Biotech News
Related news
EMBCEmbecta2026-08-07 10:30 EST
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
EMBCEmbecta2026-08-07 10:00 EST
embecta Announces Quarterly Cash Dividend
MNKDMannKind2026-07-28 20:01 EST
MannKind to Report Second Quarter Financial Results and Host Conference Call on August 5, 2026
VANIVivani Medical2026-06-26 11:30 EST
Vivani Medical Announces Appointment of August J. Moretti to Board of Directors and Retirement of Dr. Dean Baker
VANIVivani Medical2026-06-25 11:30 EST
Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management
MNKDMannKind2026-05-27 13:05 EST
MannKind to Showcase New Data at ADA 2026 Advancing Understanding of Inhaled Insulin (Afrezza®) in Pediatric Care, Pregnancy and Use with Automated Insulin Delivery (AID) Systems
Embecta
Global Diabetes Care Embecta is a global diabetes-care company built on a nearly century-long history in insulin delivery. Its products are used by people who self-administer injectable therapies and by healthcare systems supporting diabetes management. Injection-Device Portfolio The company's core portfolio includes pen needles and...
Recent company news
EMBCEmbecta2026-08-07 10:30 EST
Embecta Corp. Reports Third Quarter Fiscal 2026 Financial Results
EMBCEmbecta2026-08-07 10:00 EST
embecta Announces Quarterly Cash Dividend
EMBCEmbecta2026-07-23 21:00 EST
embecta to Report Fiscal Third Quarter Financial Results
EMBCEmbecta2026-06-16 10:30 EST
embecta appoints Nimish Muzumdar as SVP and President, North America
EMBCEmbecta2026-06-01 21:00 EST
embecta to Participate in Investor Events
Stock data
- Close
- 3.50 USD
- Market cap
- 207.05M USD
- Exchange
- NASDAQ
- Sector
- Biopharma
- Location
- United States